SEC Form 4 · accession 0001104659-18-019365
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Trachtenberg
Officer — GC, CCO & Secretary
Period of report
Mar 19, 2018
Accepted (ET)
Mar 21, 2018 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Mar 19, 2018 | S | 3,471 | $1.70 | D | 198,093 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 11,501 restricted stock units, which were previously granted on March 17, 2016 and which vested on March 17, 2018.